跳至主要内容
临床试验/NCT03621813
NCT03621813进行中(未招募)不适用

Progressive Activity-Based Rehabilitation in Veteran Cancer Survivors With Chronic Pain

VA Office of Research and Development1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2019年8月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
9
试验地点
1
主要终点
Pain Visual Analog Scale Change

研究概览

简要总结

Exercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a: common, debilitating, and inadequately treated symptom in a growing population. This could lead to a larger investigation to fill critical gaps in the literature and at the same time help discover a new model of care for Veterans with chronic pain. The ultimate goal is to reduce this type of pain for the growing population of cancer survivors while simultaneously reducing the need for problematic opioid management.

详细描述

Persistent or chronic neuropathic pain, either post-thoracotomy persistent pain (PTPP) or chemotherapy-induced peripheral neuropathy (CIPN) occurs in a majority of lung cancer patients. Thus, not only is this neuropathic pain widespread; there is no way to prevent its development, and long-term use of opioids for control of symptoms could result in addiction. Ultimately, PTPP and CIPN can lead to long-term suffering and disability during the post-treatment phase.(NSCLC), which represents about 85% of lung cancer cases.This is the first project of its kind and the potential impact of this research is large, because exercise training will be a prescription and the first approach for which NSCLC survivors can self-manage chronic neuropathic pain. The ultimate goal of the investigators' work is to reduce neuropathic pain for the growing population of cancer survivors while simultaneously reducing the need for problematic pharmacologic management. Therefore, results of this study have potential for high impact on symptom care because it will allow effective neuropathic pain treatment to be in full control of the Veteran, and likely restore function that is lost during the chronic pain experience.

Specific Aims:

  1. To determine the feasibility of conducting an exercise rehabilitation intervention in Veterans with NSCLC and PTPP or CIPN.
  2. To determine the effects of a VAMHCS-supervised activity rehabilitation program on chronic pain compared to delayed control.
  3. To assess changes in fitness, strength, physical function, fatigue, and quality of life (QoL) after activity-based rehabilitation compared to control period.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
60 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 60-80 years
  • Diagnosis with lung cancer
  • History of treatment with either thoracotomy procedure or neurotoxic chemotherapy or both
  • Completion of thoracotomy or chemotherapy > or = 6 months
  • Ability to walk on a treadmill
  • Karnofsky performance status > 70
  • Score > 1 Neuropathic Pain Scale

排除标准

  • Presence of metastatic (stage IV)
  • Life expectancy < 6 months
  • Musculoskeletal or medical conditions which preclude participation in an exercise program

研究组 & 干预措施

Control

Other

Participants maintain their current activity level.

干预措施: Control (Other)

Exercise Rehabilitation

Active Comparator

Participants will exercise 2x/week at training facilities and at home one day a week.

干预措施: Exercise Rehabilitation (Behavioral)

结局指标

主要结局

Pain Visual Analog Scale Change

时间窗: Measured at baseline, after 6 weeks control, and after 6 week intervention

Scale of 0 (no pain) to 100 (worst imaginable pain)

次要结局

  • Fitness Change(Measured at baseline, after 6 weeks control, and after 6 week intervention)
  • Patient-Reported Outcomes Measurement System Neuropathic Pain Quality (PROMIS-PQ Neuro) Change(Measured at baseline, after 6 weeks control, and after 6 week intervention)
  • Strength Change(Measured at baseline, after 6 weeks control, and after 6 week intervention)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验